Literature DB >> 15627069

Human beta-defensin 3 (hBD-3) expression in A431 cell line and human vulval tumors.

Vladimir M Shnitsar1, Igor L Lisovskiy, Maria A Soldatkina, Serhiy V Nespryadko, Olexander V Turchak, Alla B Vinnitskaya, Peter V Pogrebniy.   

Abstract

UNLABELLED: The present work was AIMED on the study of human beta-defensin 3 (hBD-3) gene expression in A431 cell line and human vulval tumors.
MATERIALS AND METHODS: Twenty surgical specimens of both malignant and conventionally normal human vulval tissues have been analyzed for the presence of hBD-3 mRNA by semi-quantitative reverse transcription polymerase chain reaction (RT-PCR). In vitro experiments have been carried out on A431 cells.
RESULTS: It has been shown that hBD-3 gene expression in A431 cells was induced upon EGF stimulation. In human vulval tissues, in 8 cases the expression of hBD-3 gene was registered only in tumor tissue and was absent in paired controls, and 7 cases were characterized by significant increase of hBD-3 gene expression in malignant transformed epithelium in comparison with normal ones. Remaining surgical specimens showed either equal levels of hBD-3 expression or even moderate elevation of hBD-3 expression in normal tissue. In 2 specimens of tumor tissue hBD-3 mRNA was not observed.
CONCLUSION: In human vulval epithelium, the increase in hBD-3 mRNA expression was predominantly associated with malignant phenotype.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15627069

Source DB:  PubMed          Journal:  Exp Oncol        ISSN: 1812-9269


  2 in total

1.  Effect of human beta-defensin-3 on head and neck cancer cell migration using micro-fabricated cell islands.

Authors:  Kevin Wang; Joanne H Wang; Harihara Baskaran; Russell Wang; Rick Jurevic
Journal:  Head Neck Oncol       Date:  2012-06-28

2.  Pattern of mRNA expression of beta-defensins in basal cell carcinoma.

Authors:  T Gambichler; M Skrygan; J Huyn; F G Bechara; M Sand; P Altmeyer; A Kreuter
Journal:  BMC Cancer       Date:  2006-06-23       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.